Neuraxpharm is the European leader in therapeutics for central nervous system (CNS) disorders. Over 35 years we have gained experience in international CNS markets and as specialists in this field we bring broad and unique expertise to our research and final products.

We are involved in the development and research of pharmaceuticals. Our main areas of focus are urology, diabetes, dermatology, transplant medicine, immunology, CNS diseases, oncology and disease management. We offer products related to the prevention of organ healing after kidney, liver and heart transplantation.

We are the world's largest manufacturer of generic pharmaceuticals and active pharmaceutical ingredients. We sell human and veterinary pharmaceuticals. We focus on cardiology, oncology and over-the-counter medicines.

We are engaged in the sale of drugs for the fields of neurology or psychiatry and the development of new drugs for the treatment of central nervous system disorders. We offer drugs for depression, schizophrenia and alcohol addiction, Alzheimer's, Parkinson's or Huntington's disease. We organize seminars for the professional public.

We develop breakthrough therapeutic methods to improve the health of humans and animals. As one of the world's leading research-driven biopharmaceutical companies, we create value through innovation in areas that have previously lacked appropriate treatments.